The present invention relates to compounds of formula (I):
or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease.
本发明涉及式(I)化合物或其药学上可接受的盐。这些化合物抑制
丝氨酸蛋白酶,特别是丙型肝炎病毒
NS3-NS4A
蛋白酶。